You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mechlorethamine

Showing 26 - 50 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,

Not yet recruiting
  • Bilateral Retinoblastoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Aug 17, 2022

Unilateral Retinoblastoma Trial in United States (Melphalan)

Active, not recruiting
Has Results
  • Unilateral Retinoblastoma
  • Los Angeles, California
  • +11 more
May 19, 2022

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +11 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 29, 2021

Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)

Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
Dec 27, 2021

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

CNS Embryonal Tumor, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered, Germ Cell Tumor Trial in Minneapolis, Portland

Active, not recruiting
  • Central Nervous System Embryonal Neoplasm
  • +9 more
  • Minneapolis, Minnesota
  • +1 more
Oct 25, 2021

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Hematopoietic and Lymphoid System Tumor Trial in Houston (procedure, drug, biological, radiation)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Mycosis Fungoides Trial in Leiden (Chlormethine)

Recruiting
  • Mycosis Fungoides
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 29, 2022

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Mycosis Fungoides Trial in Philadelphia (Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy)

Withdrawn
  • Mycosis Fungoides
  • Mechlorethamine Hydrochloride Gel
  • Total Skin Electron Beam Radiation Therapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 25, 2018

Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

Completed
  • Ewing Sarcoma
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 14, 2020

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma Trial in Durham, Portland (procedure, drug, other)

Completed
  • Plasma Cell Leukemia
  • Recurrent Plasma Cell Myeloma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Durham, North Carolina
  • +1 more
Nov 19, 2020

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston (drug, biological, procedure, radiation)

Completed
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)

Terminated
Has Results
  • Burkitt Lymphoma
  • +6 more
  • Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 30, 2020

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Alemtuzumab
  • +20 more
  • Palo Alto, California
  • +100 more
Aug 3, 2022

Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +5 more
  • Mobile, Alabama
  • +392 more
Jan 25, 2023

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021